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Abstract
Postnatal depression (PND) has an estimated prevalence of 6.5 to 12.9%. In addition to the direct consequences for women, PND also
interferes with thematernal-infant interaction, contributing to long-term cognitive and emotional impairments in exposed offspring. It is
unclear how PND differs from major depressive disorder (MDD) more generally, and if PND represents a distinct subtype of
depression. We explored whether women with a history of PND have specific differences in brain activation associated with sex
hormone changes during the late luteal phase of the menstrual cycle, compared to parous women with either a past history of MDD
outside of the postnatal period, or an absent history of MDD (‘never depressed’). Thirty mothers (history of PND (n = 10), history of
MDD (n = 10), and ‘never depressed’ (n = 10)) underwent blood-oxygen-level-dependent (BOLD) functional magnetic resonance
imaging (fMRI) acquisition during an emotional faces task. Amygdala activity was analysed using a region of interest (small volume
correction) approach. There was a significant reduction in BOLD response to positive emotional faces in the right amygdala in women
with a history of PND compared to women with a history of MDD. A similar but non-significant trend was found in the left amygdala
in women with a history of PND compared to ‘never depressed’ women. Our findings support the hypothesis that women with
vulnerability to PND represent a distinct subgroup of women with a differential sensitivity to changes in sex hormones. Further, albeit
highly tentative, they provide a putative biomarker that could assist in detection of women at-risk to PND.
Keywords Postnatal depression (PND) . Postpartum depression . Major depressive disorder (MDD) . Hormones . Functional
magnetic resonance imaging (fMRI) . Amygdala
Introduction
The risk of major depressive disorder (MDD) is significantly
increased in women following childbirth. The need for more
effective treatments is supported by findings that postnatal
depression (PND) is more resistant to conventional antide-
pressants (Hendrick et al. 2000), and suicide remains the sec-
ond leading cause of perinatal death in the UK (Stein et al.
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2018). Some believe that PND represents a distinct subtype of
depression. However, others suggest that PND is a useful lay
term, which reduces stigma, but is less useful as a medical
concept (Brockington 2004). In order to develop more effec-
tive treatments, we need to better understand the biology of
the disorder, and how/if PND differs from MDD.
It has been suggested that a key trigger for PND is the
abrupt decrease in sex hormones that occurs postpartum
(Heidrich et al. 1994), and women developing PND have dif-
ferential sensitivity to these changes. This hypothesis is sup-
ported by findings that, compared to women without any his-
tory of depression, only those with a history of PND devel-
oped depressive symptoms following pharmacological sup-
pression of gonadal steroids (Bloch et al. 2000). However,
the absence of an additional control group with previous
MDD (i.e. independent of childbirth) meant that it was impos-
sible to determine whether findings were due to a specific
sensitivity to hormone changes in women with PND, as op-
posed to MDD more generally.
Previous functional magnetic resonance imaging (fMRI)
studies have reported, that compared to controls, patients with
MDD exhibit reduced amygdala activation when viewing
happy emotional faces and increased amygdala activation
when presented with negative emotional faces (see
Groenewold et al. 2013) for review). Whilst other brain re-
gions have also been linked with MDD (e.g. anterior cingulate
cortex (Groenewold et al. 2013)), the amygdala has been the
most reliable region to have been implicated. Preliminary
studies of brain function in women during an acute episode
of PND, compared to controls, have reported conflicting re-
sults with, for example a reduction in amygdala activity to
negative emotional faces (Moses-Kolko et al. 2010) or nega-
tively valenced stimuli (Silverman et al. 2007). However, pre-
vious imaging studies investigating PND are small and likely
to have been confounded by variables including timing of
depression onset, breastfeeding status and suppression of the
hypothalamic-pituitary-adrenal axis during this period.
Furthermore, there have been no studies to date that have
investigated whether ‘at risk’ women with a history of early-
onset PND (i.e. within 8 weeks of birth (Forty et al. 2006))
have a well-defined neural response to changes in sex hor-
mones, consistent with the concept of a distinct diagnostic
nosology.
Therefore, we explored whether women with a history of
PND have a specific ‘neural signature’ associated with sex
hormone changes associated with the late luteal phase of the
menstrual cycle, compared to women with either a history of
‘non-reproductive’ MDD, or those without any history of
MDD (i.e. ‘never depressed’). We focused on the late luteal
phase as the abrupt drop in plasma estradiol and progesterone
concentration at this time resembles, in a scaled-down way,
the postnatal hormonal milieu. Previous studies suggest that
cognitive biases associated with active depression are also
frequently observed following remission when patients are
stressed or in a dysphoric mood (Ruhe et al. 2019). We
hypothesised that the late luteal phase would represent a dis-
crete biological stressor to women with a history of PND, but
not to women in the other groups and, further, that women
with a history of PND would have increased amygdala acti-
vation to negative and reduced activation to positive faces
compared to both other groups.
Methods
Participants
We recruited 30 right-handed parous women with regular
menstrual cycles aged 18–45 years (comprising 10 with a
history of PND, 10 with a history of MDD, and 10 ‘never
depressed’ women). Participants were screened to exclude
current mental illness, premenstrual syndromes (e.g. pre-
menstrual dysphoric disorder (PMDD)), pregnancy, IQ <
80, medical conditions affecting brain function and the
current use of medication (including the contraceptive
pill).
A past history of PND was defined as a diagnosis within
8 weeks of childbirth (Forty et al. 2006) (and the absence of
MDD at other times). Conversely, a past history of MDD was
defined by diagnosis of at least one episode of MDD in the
past (and the absence of an episode following childbirth).
Study design
We employed a case-control design to analyse the effect of
late luteal phase decline in sex hormones on brain function.
Participants attended the Institute of Psychiatry, Psychology
& Neuroscience (IoPPN) during the late luteal phase of the
menstrual cycle. Menstrual cycle tracking was assisted by
home ovulation testing sticks and confirmed by a blood test
on the scanning day (i.e. to measure estradiol, progesterone,
follicular stimulating hormone (FSH) and luteinizing hormone
(LH) concentration). This approach enabled us to target the
late luteal phase more precisely.
Psychometric and questionnaire measures
Participants underwent an investigation for psychiatric disor-
der using the Structured Clinical Interview for DSM-IVAxis I
and II Disorders. Anxiety and depression levels were mea-
sured on the day of scanning by Beck Anxiety Inventory
(BAI), Beck Depression Inventory (BDI) and the State Trait
Anxiety Inventory.
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Endocrine determinants
Blood was collected into tubes without anticoagulant and
allowed to clot. Samples were centrifuged for 12 min at
1500g and serum separated within 4 h. Hormone concentra-
tions were quantified using competitive immunoassays (estra-
diol and progesterone) and two-site sandwich immunoassays
(LH and FSH) using electro-chemiluminescent technology
(see Table S1 in the Supplementary Material that
accompanies this article).
fMRI paradigms
The fMRI paradigm employed was the emotional faces
task (Ekman and Friesen 1976) in a block design (see
Supplementary Material for further information on this
paradigm in the context of depression (Stuhrmann et al.
2011)). Participants were presented with positive (happy),
negative (angry) and neutral facial expressions in a
pseudo-randomised order, from a standardised series of
prototypical facial expressions. Each facial stimulus was
presented for 2 s, and the participant was asked to judge
the gender of the face by pressing the left button for a
female face and the right button for a male face.
MRI acquisition
Scanning was performed using a 3 Tesla MR750 GE
scanner using a 12-channel head coil. Gradient echo pla-
nar images (EPI) (FOV = 240 mm, TR/TE = 2000/30,
64 × 64 matrix, voxel size = 3.75 × 3.75 × 3.3 mm, 41
slices) were obtained for each subject. For purposes of
anatomical localisation, a matched T1-weighted structural
MRI (FOV = 270 mm, TR/TE/TI = 7.312/3.016/400 ms,
256 × 256 × 196 matrix, slice thickness = 1.2 × 1 × 1 mm)
was acquired for each participant.
Data pre-processing
Data were pre-processed using SPM12. EPI volumes for
each subject were realigned to their mean. EPI and ana-
tomical images were co-registered using the mean EPI
and T1-weighted volumes. T1-weighted volumes were
segmented, with the resulting deformation fields used to
normalize subjects’ EPI volumes to the MNI template.
Images were spatially smoothed using a 6-mm Gaussian
kernel (FWHM).
fMRI data analysis
Experimental conditions (i.e. happy, angry, neutral) were
entered into the first level model as regressors of interest
and modelled as blocks of 16 s. Additionally, realignment
parameters for the EPI volumes were added as nuisance
variables. All data were high pass filtered at 128 Hz.
Con t r a s t s o f i n t e r e s t , ‘Happ y>Neu t r a l ’ a n d
‘Angry>Neutral’, were assessed for group differences in
second level analysis.
Statistical maps were initially thresholded at voxel-wise
p < 0.005. Due to the small size of the amygdala we used a
small volume correction (SVC) approach using the bilateral
anatomical AAL mask p < 0.005, pFWE < 0.05.
We report data from the amygdala region of interest in the
main text; for completeness, we also report results from whole
brain analysis in the online supplementary material.
Results
Demographics
Groups did not differ significantly with respect to age, IQ,
BAI score, BDI score, STAI scores, hormone concentration
levels, number of past depressive episodes or the average




We report a significant reduction in BOLD signal in women
with past PND compared to past MDD whilst viewing ‘hap-
py’ vs. ‘neutral’ faces in the right amygdala (pFWE = 0.044,
k = 8, Z = 3.26, xyz = 24 − 4 − 20, d= − 1.49), with a trend in
the left amygdala (pFWE = 0.07, k = 1, Z = 3.10, xyz = 26 − 2 −
22, d= − 1.44).
A similar but non-significant trend was also found in the
left amygdala following the same contrast in women with past
PND compared to ‘never depressed’ women (pFWE = 0.08,
k = 5, Z = 3.03, xyz = 24 − 4 − 20, d= 0.96) (Fig. 1).
There were no significant between-group differences in
BOLD response in the amygdala in contrasts of ‘angry’ vs.
‘neutral’ faces.
Discussion
Our findings support the hypothesis that women with vulner-
ability to PND have a distinct neural response to positive
facial emotion during the late luteal phase of the menstrual
cycle. More specifically, a region of interest analysis found
women with a past history of PND had significantly reduced
brain activation in the right amygdala to happy faces, and a
(non-significant) reduction in the left amygdala, compared to
women with previous MDD, with a similar trend in the left
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amygdala when compared to ‘never depressed’ women.
However, due to our small sample size, these results only
survived with small volume correction.
The finding of reduced right amygdala activity to happy
faces is consistent with a core information processing bias (i.e.
attending less to positive stimuli) reported in individuals at
risk of depression (Gotlib et al. 2004) and in women with
PMDD (Rubinow et al. 2007). Further, in women with
PMDD, increased right amygdala activity to negative stimuli
(emotional words) has also been reported during the luteal
phase compared to asymptomatic controls (Protopopescu
et al. 2008). This study like ours was limited by its small
sample size but adds support to the hypothesis that vulnera-
bility to ‘reproductive depression’ (e.g. PMDD and PND)may
be underpinned by an inherent difference in adaptation to
rapid changes in neuroactive steroid concentrations.
However, larger studies are needed to replicate our results
and explore the relationship with angry and other negative
stimuli (e.g. sad) to fluctuations in sex hormones in women
with past PND, which may underpin their vulnerability to
more profound changes post childbirth. Further, they suggest
the need to search for putative predictive/prognostic bio-
marker(s) in women at-risk of PND. Larger studies are now
required to replicate our findings.
Table 1 Sample characteristics
Mean (SD)
Never depressed Past PND Past MDD ANOVA
Age 36.2 (5.18) 35.9 (3.7) 36.00 (5.05) F(2,27) = 0.01, p = 0.99
IQ 111.7 (7.49) 115.6 (9.68) 116.2 (8.16) F(2,27) = 0.83, p = 0.45
BAI 5.70 (7.28) 13.77 (17.44) 8.80 (7.39) F(2,26) = 1.19, p = 0.31
BDI 5.60 (6.995) 11.11 (8.72) 8.00 (5.53) F(2,26) = 1.41, p = 0.26
STAI-T 32.5 (10.86) 42.33 (15.01) 34.2 (8.14) F(2,26) = 1.93, p = 0.17
STAI-S 37.6 (9.72) 45.66 (12.96) 43.6 (9.93) F(2,26) = 1.43, p = 0.26
LH 2.58(2.28) 3.4 (2.8) 4.21 (4.06) F(2,26) = 0.62, p = 0.55
FSH 3.65(1.57) 4.76 (2.49) 4.37 (2.66) F(2,26) = 0.55, p = 0.58
Progesterone 34(19.95) 21.9 (22.13) 22.7 (15.56) F(2,26) = 1.13, p = 0.34
Estradiol 539.22(212.56) 343 (217.79) 327.9 (164.22) F(2,26) = 3.26, p = 0.06
Depressive episodes N/A 1.3 (0.48) 1.6 (0.966) F(1,18) = 0.77, p = 0.39
Menstrual cycle day at scan 23.5 (3.06) 23.2 (3.15) 22.75 (2.49) F(2,25) = 0.14, p = 0.86
PND postnatal depression,MDD major depressive disorder, BAI Beck Anxiety Inventory, BDI Beck Depression
Inventory, STAI-T and STAI-S State-Trait Anxiety Inventory, LH luteinizing hormone, FSH follicular stimulating
hormone
Fig. 1 Group differences during an fMRI task when looking at happy
faces compared to neutral faces. a Region of interest analysis: decrease in
activation in the right amygdala in the past postnatal depression group
(PND) compared to the past major depressive disorder (MDD) group
(p = 0.044). There were no significant differences observed between the
other groups. b Plot of mean blood oxygenation level–dependent
(BOLD) signal in the right amygdala cluster with peak at coordinates at
24 4–20 (never depressed, past postnatal depression group (PND), past
major depressive disorder group (MDD))
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